Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Int J Radiat Biol. 2020 Mar 2;97(8):1109–1120. doi: 10.1080/09553002.2020.1730012

Figure 7.

Figure 7.

Regorafenib inhibits TNBC cell migration and invasion. Wound healing assays of (A). MDA-MB-231 and (B). SUM159PT cells at 0 h, 24 h, 48 h and 72 h treatment with Regorafenib (10 μM or 5 μM respectively) compared to control (DMSO alone) is shown. Graphical representation shows the relative percentage of wound closure in TNBC cells. Images show the transwell analysis of (C). MDA-MB-231 and (D). SUM159PT cells at 24 and 48 h treatment with Regorafenib or DMSO alone. (E, F). The number of migrated cells per field is shown in the graphical representation of respective cell lines. *p ≤ .01.